GO:0098987 regulation of modification of synapse structure, modulating synaptic transmission: Synaptic Plasticity Regulation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0098987 describes any process that regulates structural changes at synapses and thereby modulates synaptic transmission [1, 2].
• It is a biological_process term that sits at the interface of structural plasticity and functional synaptic strength [1, 8].
• Key molecular players include metabotropic glutamate receptors (mGluRs), ionotropic receptors, scaffolding proteins like gephyrin, and post-translational modifiers such as SUMO [1, 2, 5, 8].
• Dysregulation of this process is linked to neurodevelopmental disorders, Alzheimer's disease, and other neurological conditions.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal testing of genes involved in this regulatory process [2, 5].
• Studying this term requires combining imaging, electrophysiology, proteomics, and transcriptomics to capture structural and functional changes [3, 4, 6].
Description
The Gene Ontology (GO) term GO:0098987, regulation of modification of synapse structure, modulating synaptic transmission, defines a biological process in which cellular mechanisms control changes to synaptic architecture and, as a consequence, influence the efficacy of synaptic transmission [1, 2]. This term captures the dynamic interplay between the physical remodeling of synapses and their functional output, a concept central to synaptic plasticity, learning, and memory. Synapses are not static structures; their size, shape, and molecular composition are continuously regulated by activity, and these structural modifications directly affect how signals are transmitted between neurons [1, 8]. Understanding this process is essential for researchers investigating normal brain function and the pathological mechanisms underlying neurological and psychiatric disorders. The regulation of synaptic structure involves a diverse array of molecules, including neurotransmitter receptors, scaffolding proteins, cell adhesion molecules, and post-translational modifiers [1, 2, 5, 8]. For example, metabotropic glutamate receptor trafficking is a key regulatory mechanism that alters synaptic strength by controlling receptor availability at the membrane. Similarly, SUMOylation of synaptic proteins has emerged as a critical post-translational modification that orchestrates the molecular organization of the synapse and modulates transmission. This article provides a research-grade overview of GO:0098987, integrating authoritative GO definitions with evidence from real PubMed literature to support researchers in designing experiments and interpreting data related to synaptic structure and function.
regulation of modification of synapse structure, modulating synaptic transmission At A Glance
| GO ID | GO:0098987 |
|---|---|
| GO term | regulation of modification of synapse structure, modulating synaptic transmission |
| Ontology | biological_process |
| Synonym | None |
| Major function | Regulation of structural changes at synapses that modulate synaptic transmission |
| Definition | Any process that regulates the modification of synaptic structure and as a result regulates synaptic transmission. |
| Related processes | Synaptic plasticity, receptor trafficking, post-translational modifications, cytoskeletal dynamics |
| Key molecules | mGluRs, iGluRs, gephyrin, SUMOylation machinery, TRP channels |
What Is GO:0098987?
GO:0098987 is defined by the Gene Ontology as any process that regulates the modification of synaptic structure and as a result regulates synaptic transmission. In other words, it encompasses the regulatory mechanisms that control structural changes at synapses, such as alterations in spine morphology, receptor clustering, or synaptic protein composition, which in turn modulate the strength and efficacy of synaptic signaling [1, 2, 8]. This term does not describe the structural modification itself, but rather the regulatory processes that govern it and its functional consequences for transmission.
Why Is regulation of modification of synapse structure, modulating synaptic transmission Important in Cell Biology?
GO:0098987 is important because it provides a conceptual framework for understanding how structural changes at synapses are regulated to control synaptic transmission, a fundamental process underlying learning, memory, and brain function. Dysregulation of this process is implicated in a wide range of neurological and psychiatric disorders, including Alzheimer's disease, developmental disorders, and addiction. By studying this term, researchers can identify molecular targets that modulate synaptic structure and function, potentially leading to therapeutic interventions [1, 2, 5, 8].
• Underlies synaptic plasticity, the cellular basis of learning and memory.
• Dysregulation is linked to Alzheimer's disease and other neurodegenerative conditions.
• Involved in neurodevelopmental disorders such as autism spectrum disorders.
• Modulates synaptic transmission strength, affecting information processing [1, 4].
• Post-translational modifications like SUMOylation regulate synaptic organization.
• Receptor trafficking (e.g., mGluRs, nAChRs) is a key regulatory mechanism [1, 5].
• Scaffolding proteins such as gephyrin control inhibitory synapse dynamics.
• TRP channel trafficking influences synaptic structure and function.
• Provides targets for therapeutic intervention in neurological diseases.
• Essential for understanding activity-dependent synapse remodeling [1, 8].
What Happens During regulation of modification of synapse structure, modulating synaptic transmission?
Initiation by Neuronal Activity
In simple terms: When neurons are active, they trigger signals that start the process of changing synapse structure.
Neuronal activity, such as high-frequency stimulation or sensory experience, initiates signaling cascades that lead to structural modifications at synapses [1, 4]. This can involve calcium influx through NMDA receptors and activation of downstream kinases. For example, 7,8-dihydroxyflavone, a TrkB agonist, rapidly potentiates hippocampal synaptic transmission, demonstrating activity-dependent regulation. These initial signals set the stage for changes in receptor trafficking and cytoskeletal reorganization.
Receptor Trafficking and Membrane Insertion
In simple terms: Receptors are moved into or out of the synapse to change how strongly signals are transmitted.
A key regulatory step is the trafficking of neurotransmitter receptors to and from the synaptic membrane. Metabotropic glutamate receptors (mGluRs) undergo dynamic trafficking that modulates synaptic transmission. Similarly, nicotinic acetylcholine receptors (nAChRs) are regulated by post-translational modifications that affect their surface expression and function. TRP channels also traffic to the membrane in response to signals, influencing synaptic structure and transmission. This trafficking is tightly controlled by interacting proteins and modifications [1, 5].
Post-Translational Modifications of Synaptic Proteins
In simple terms: Chemical tags are added to synaptic proteins to control their interactions and stability.
Post-translational modifications such as SUMOylation, phosphorylation, and ubiquitination regulate the molecular organization of the synapse. SUMOylation of synaptic proteins can alter protein-protein interactions, leading to changes in synaptic structure and function. For instance, SUMOylation of gephyrin, a scaffolding protein at inhibitory synapses, regulates its clustering and thereby inhibitory synaptic strength [2, 8]. These modifications provide a rapid and reversible way to modulate synaptic transmission [2, 5].
Cytoskeletal Rearrangement and Structural Remodeling
In simple terms: The internal skeleton of the synapse is reorganized to change its shape and size.
Actin and other cytoskeletal elements undergo dynamic rearrangement to support changes in synaptic structure, such as spine enlargement or retraction [1, 8]. This remodeling is regulated by signaling pathways downstream of receptor activation and involves scaffolding proteins like gephyrin at inhibitory synapses. The structural changes can persist, leading to long-term alterations in synaptic transmission [1, 3].
Feedback and Homeostatic Regulation
In simple terms: The synapse monitors its own activity and adjusts to maintain stability.
Homeostatic mechanisms ensure that synaptic transmission remains within a functional range. For example, prolonged changes in activity can trigger compensatory adjustments in receptor number or release probability [1, 8]. Synapse-to-nucleus communication allows activity-dependent signals to alter gene expression, contributing to long-term structural and functional changes. This feedback regulation is critical for preventing runaway excitation or silencing.
Key Genes Involved in GO:0098987 regulation of modification of synapse structure, modulating synaptic transmission
The following genes and proteins are key players in the regulation of synaptic structure and transmission, as supported by the cited literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GRM1 | Metabotropic glutamate receptor 1; regulates synaptic transmission via trafficking | Studied for mGluR trafficking and synaptic plasticity |
| GRM5 | Metabotropic glutamate receptor 5; modulates synaptic strength | Target for mGluR trafficking studies |
| GRIN1 | NMDA receptor subunit; mediates calcium influx for plasticity | Key for activity-dependent structural changes |
| GRIA1 | AMPA receptor subunit; mediates fast excitatory transmission | Receptor trafficking in synaptic potentiation |
| GPHN | Gephyrin; scaffolds glycine and GABA-A receptors at inhibitory synapses | Regulates inhibitory synaptic strength and dynamics |
| SUMO1 | Small ubiquitin-like modifier 1; post-translational modifier | SUMOylation of synaptic proteins |
| UBC9 | SUMO-conjugating enzyme; catalyzes SUMOylation | Enzyme for SUMOylation of synaptic proteins |
| TRPC1 | Transient receptor potential channel 1; calcium-permeable channel | Trafficking influences synaptic structure |
| TRPC6 | TRP channel 6; involved in synaptic plasticity | Channel trafficking in neurons |
| CHRNA4 | Nicotinic acetylcholine receptor alpha4 subunit | Regulated by post-translational modifications |
| CHRNB2 | Nicotinic acetylcholine receptor beta2 subunit | nAChR function and trafficking |
| BDNF | Brain-derived neurotrophic factor; promotes synaptic plasticity | TrkB signaling and structural changes |
| NTRK2 | TrkB receptor; binds BDNF and activates signaling | Mediates rapid synaptic potentiation |
| DLG4 | PSD-95; scaffolding protein at excitatory synapses | Organizes postsynaptic density and receptor clustering |
| ACTB | Beta-actin; cytoskeletal protein | Cytoskeletal remodeling at synapses |
| CAMK2A | Calcium/calmodulin-dependent protein kinase II alpha | Activity-dependent structural plasticity |
| MAPK1 | Mitogen-activated protein kinase 1; signaling kinase | Downstream of receptor activation |
How Is regulation of modification of synapse structure, modulating synaptic transmission Regulated?
The regulation of modification of synapse structure, modulating synaptic transmission is itself subject to multiple layers of control. Neuronal activity is a primary regulator, initiating signaling cascades that lead to structural changes [1, 4]. Post-translational modifications, such as SUMOylation, provide reversible control of synaptic protein function and interactions. Receptor trafficking is regulated by interacting proteins and modifications, including phosphorylation and ubiquitination [1, 5]. Additionally, synapse-to-nucleus communication allows activity-dependent changes in gene expression to feed back and modulate synaptic structure and function over longer timescales. Homeostatic mechanisms also adjust synaptic strength to compensate for prolonged changes in activity.
regulation of modification of synapse structure, modulating synaptic transmission and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GRM1 | Alzheimer's disease, schizophrenia | Knockout mouse, point mutation knock-in |
| GPHN | Hyperekplexia, epilepsy | Knockout mouse, overexpression |
| SUMO1 | Neurodevelopmental disorders | Knockout, knock-in of SUMOylation sites |
| CHRNA4 | Nicotine addiction, epilepsy | Point mutation knock-in, knockout |
| TRPC6 | Depression, anxiety | Overexpression, knockout |
Alzheimer's Disease
Dysregulation of synaptic structure and function is an early hallmark of Alzheimer's disease. Synapse-to-nucleus communication pathways are disrupted in Alzheimer's disease, contributing to synaptic loss and cognitive decline. Abnormal regulation of synaptic structure may exacerbate amyloid-beta-induced toxicity and tau pathology.
Neurodevelopmental Disorders
Developmental disorders such as autism spectrum disorders and intellectual disability are often linked to mutations in genes that regulate synaptic structure and transmission. Disrupted synapse-to-nucleus communication during development can lead to abnormal circuit formation and function.
Addiction and Psychiatric Disorders
Drug addiction involves long-lasting structural and functional changes at synapses, particularly in reward circuits. The regulation of synaptic structure by receptor trafficking and post-translational modifications contributes to addictive behaviors [1, 5]. Similarly, mood disorders may involve dysregulated synaptic plasticity.
From regulation of modification of synapse structure, modulating synaptic transmission-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate synaptic structure? | CRISPR knockout in primary neurons or cell lines |
| Does a specific mutation affect synaptic transmission? | Point mutation knock-in via CRISPR |
| How does tagging a protein affect its function? | Knock-in of fluorescent or epitope tag |
| Does overexpression of gene Y alter synapse morphology? | CRISPR overexpression (e.g., CRISPRa) |
| What is the role of SUMOylation on synaptic proteins? | Knock-in of SUMOylation-deficient mutants |
| How does receptor trafficking change with activity? | Live imaging with tagged receptors in knockout background |
How to Study the regulation of modification of synapse structure, modulating synaptic transmission Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Patch-clamp electrophysiology | Synaptic transmission strength | Assess functional impact of structural changes [4, 8] |
| Confocal microscopy | Spine morphology, receptor clustering | Visualize structural changes [1, 6] |
| Mass spectrometry | Protein composition and modifications | Identify SUMOylated synaptic proteins |
| RNA-seq | Gene expression changes | Discover activity-dependent transcriptional programs [3, 7] |
| FRAP | Protein dynamics and turnover | Measure receptor trafficking |
| Proximity ligation assay | Protein-protein interactions | Detect SUMOylation of synaptic proteins |
| Calcium imaging | Intracellular calcium signals | Monitor activity-dependent signaling |
| Western blot | Protein levels and modifications | Validate changes in synaptic proteins |
Electrophysiology
Patch-clamp recordings measure synaptic transmission strength, such as mEPSC amplitude and frequency, to assess functional changes resulting from structural modifications [4, 8]. This method is essential for linking structural changes to transmission efficacy.
Imaging of Synaptic Structure
Confocal or two-photon microscopy with fluorescently labeled synaptic proteins or dyes allows visualization of spine morphology, receptor clustering, and synaptic density [1, 6]. Time-lapse imaging can capture dynamic changes in response to activity.
Proteomics and Post-Translational Modification Analysis
Mass spectrometry-based proteomics can identify proteins and their post-translational modifications, such as SUMOylation, in synaptic fractions. This provides a global view of the molecular changes underlying structural regulation.
Transcriptomics and Gene Expression Profiling
RNA sequencing (RNA-seq) of neurons after activity or genetic manipulation reveals changes in gene expression that may regulate synaptic structure [3, 7]. This can identify downstream effectors of synapse-to-nucleus communication.
How CRISPR Can Be Used to Study GO:0098987 regulation of modification of synapse structure, modulating synaptic transmission
Knockout
CRISPR knockout of genes involved in synaptic structure regulation, such as GRM1 or GPHN, can reveal their necessity for synaptic transmission and structural plasticity [1, 8]. Knockout models are useful for loss-of-function studies in primary neurons or animal models.
Point Mutation
Introducing point mutations in genes like CHRNA4 or SUMOylation sites in target proteins allows precise testing of specific residues in regulating synaptic structure and function [2, 5]. This is critical for understanding post-translational modification effects.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags into endogenous loci enables real-time imaging of synaptic proteins and tracking of trafficking without overexpression artifacts [2, 6]. This approach preserves native regulation.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression of genes like BDNF or TRPC6 can test sufficiency in driving structural changes and modulating synaptic transmission [4, 6]. Overexpression models are valuable for gain-of-function studies.
How EDITGENE Supports regulation of modification of synapse structure, modulating synaptic transmission Research
Researchers studying regulation of modification of synapse structure, modulating synaptic transmission-related genes often need to determine whether a candidate gene is causally involved in structural plasticity and synaptic function. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in models, along with library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for regulation of modification of synapse structure, modulating synaptic transmission research.
Frequently Asked Questions About regulation of modification of synapse structure, modulating synaptic transmission
What is GO:0098987?
GO:0098987 is a Gene Ontology biological process term defined as any process that regulates the modification of synaptic structure and as a result regulates synaptic transmission [1, 2].
What genes are involved in regulation of modification of synapse structure, modulating synaptic transmission?
Key genes include GRM1, GRM5, GRIN1, GRIA1, GPHN, SUMO1, UBC9, TRPC1, TRPC6, CHRNA4, CHRNB2, BDNF, NTRK2, DLG4, ACTB, CAMK2A, and MAPK1, as supported by the cited literature [1, 2, 4, 5, 6, 8].
How does synaptic structure modification affect synaptic transmission?
Structural changes such as spine enlargement or receptor clustering can increase or decrease the strength of synaptic transmission by altering receptor number, release probability, or postsynaptic sensitivity [1, 4, 8].
What role does SUMOylation play in synaptic structure regulation?
SUMOylation of synaptic proteins regulates their interactions and clustering, thereby modulating synaptic structure and transmission.
Which diseases are associated with dysregulation of synaptic structure regulation?
Alzheimer's disease, neurodevelopmental disorders, addiction, and psychiatric disorders have been linked to dysregulated synaptic structure and function.
What experimental models are used to study GO:0098987?
Common models include CRISPR knockout, point mutation knock-in, tagged knock-in, and overexpression in primary neurons or animal models, combined with electrophysiology and imaging [2, 4, 6, 8].
How can I study receptor trafficking in synaptic transmission?
Live imaging with fluorescently tagged receptors, FRAP, and electrophysiology can track receptor trafficking and its impact on transmission [1, 6].
What is the role of gephyrin in inhibitory synapses?
Gephyrin scaffolds glycine and GABA-A receptors at inhibitory synapses, regulating synaptic strength and dynamics.
Can CRISPR be used to model synaptic disorders?
Yes, CRISPR knockout, point mutations, and knock-in models can recapitulate disease-associated mutations and study their effects on synaptic structure and transmission [2, 5].
What methods measure synaptic structural changes?
Confocal microscopy, two-photon imaging, and electron microscopy can visualize spine morphology and synaptic ultrastructure [1, 6].
Conclusion
GO:0098987, regulation of modification of synapse structure, modulating synaptic transmission, is a critical biological process that bridges structural plasticity and functional synaptic strength. Understanding its molecular players and regulatory mechanisms is essential for unraveling the basis of learning, memory, and neurological disorders. CRISPR-based models and advanced imaging and electrophysiology techniques provide powerful tools to dissect this process. EDITGENE offers comprehensive services to support researchers in this endeavor, from gene editing to bioinformatics.
References
- 1. Suh YH et al.. 2018. Metabotropic glutamate receptor trafficking.. Mol Cell Neurosci 91:10-24 PMID: 29604330
- 2. Chato-Astrain I et al.. 2024. Molecular Organization and Regulation of the Mammalian Synapse by the Post-Translational Modification SUMOylation.. Cells 13(5) PMID: 38474384
- 3. Šimončičová E et al.. 2024. Adult Neurogenesis, Learning and Memory.. Adv Neurobiol 37:221-242 PMID: 39207695
- 4. Kobayashi K et al.. 2018. Synapse-selective rapid potentiation of hippocampal synaptic transmission by 7,8-dihydroxyflavone.. Neuropsychopharmacol Rep 38(4):197-203 PMID: 30280523
- 5. Chrestia JF et al.. 2023. Regulation of nicotinic acetylcholine receptors by post-translational modifications.. Pharmacol Res 190:106712 PMID: 36863428
- 6. Liedtke WB et al.. 2007. TRP Channel Trafficking.. PMID: 21204515
- 7. Marcello E et al.. 2018. Synapse-to-nucleus communication: from developmental disorders to Alzheimer's disease.. Curr Opin Neurobiol 48:160-166 PMID: 29316492
- 8. Alvarez FJ. 2017. Gephyrin and the regulation of synaptic strength and dynamics at glycinergic inhibitory synapses.. Brain Res Bull 129:50-65 PMID: 27612963
